FDA has approved the Alinity s system, a new blood and plasma screening test, from Abbott, Abbot Park, Ill. The system’s automation and flexibility improve the speed and capacity of the screening process for blood and plasma centers in the United States. Alinity s features include:
- The capacity to run 600 tests per hour.
- Tracking all activities associated withthe testing and processing of each donation in accordance with regulatory requirements.
- A minimum walkaway time of 3 hours and continuous access for the technician to refill or restock.
- The capability to allow technicians to load and unload samples and supplies without pausing or stopping the system.
- An intuitive software interface, menu design, and sample-loading layout.
“In order to ensure a safe blood and plasma supply, we need access to the most advanced technologies to screen donations,” says Rachel-Louise Beddard, MD, senior vice president and chief medical officer, QualTex Laboratories. “Alinity s will help us transform the way we conduct screening so we can do our jobs most efficiently, allowing us to get the life-saving blood and plasma products to people facing their most critical situations.”
For more information, visit Abbott.